Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Options for identifying the income element of resource rent
Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options
Gluten, soy and dairy free
All our medical spa treatments are performed by a team of nurse practitioners, registered nurses, and aestheticians who receive continuing education to remain abreast of emerging treatments that benefit our patients
Kailera seeks to differentiate GLP-1/GIP agonist after partners Phase III China data Jiangsu Hengruis HRS9531 shows 17.7% placebo-adjusted weight loss at top dose Data from a Phase III study of HRS9531 in China support Jiangsu Hengruis bid for domestic approval to treat obesity, but fail to clearly differentiate the dual GLP-1/GIP agonist from established or emerging competitors
US$ 26.31
US$ 25.40
US$ 20.77
US$ 28.28
